Glutaminase1 (GLS1) inhibitor, Bis-2-(5-phenylacetamido-1,3,4-thiadazol-2-yl) ethyl sulphide reduces cancer cell proliferation in vivo (329–331). The gene discussed is GLS; the disease is cancer.